TABLE 3.
Biomarker predictor | Association with cognitive slope | Association with cognitive level | ||||
Beta | 95% Confidence interval | p-value | Beta | 95% Confidence interval | p-value | |
IL-6 | −0.002 | (−0.01, 0.01) | 0.689 | 0.17 | (−0.46, 0.80) | 0.60 |
TNF a-R-1 | −0.012 | (−0.02, −0.0002) | 0.046 | 0.80 | (−0.07, 1.67) | 0.07 |
CD14 | −0.003 | (−0.02, 0.01) | 0.668 | 0.20 | (−0.71, 1.11) | 0.67 |
CD25 | −0.006 | (−0.02, 0.01) | 0.391 | 0.43 | (−0.47, 1.33) | 0.35 |
CD163 | −0.009 | (−0.02, 0.00) | 0.134 | 0.60 | (−0.16, 1.36) | 0.12 |
Beta coefficients for the cognitive slope represent the mean difference in rate of cognitive change per log-transformed unit difference in biomarker levels. Beta coefficients for the cognitive level refer to the mean difference in baseline level of cognitive performance per log-transformed unit difference in biomarker levels. To facilitate comparison of coefficients across tests, cognitive tests were z-standardized to have a mean of 0 and variance of 1 prior to regression. A different model was estimated for each biomarker. Models are adjusted for age, sex, years of education, and vascular risk factors.